IMPACT OF GENTAMICIN ON ANTIOXIDANT ENZYMES ACTIVITY IN HEMn-DP CELLS

Insights

Gentamicin, an antibiotic, harms antioxidant defenses in melanocytes, potentially explaining its ototoxicity. This study investigated gentamicin

Area of Science:

  • Pharmacology
  • Toxicology
  • Cell Biology

Background:

  • Aminoglycoside antibiotics like gentamicin are crucial for bacterial infections but cause nephrotoxicity and ototoxicity.
  • The binding of aminoglycosides to melanin is known, yet its link to ototoxicity is unclear.
  • Melanocytes, pigment-producing cells, are potential targets for aminoglycoside-induced damage.

Purpose of the Study:

  • To investigate the effect of gentamicin on antioxidant enzyme activity in cultured human melanocytes (HEMn-DP).
  • To explore the potential role of melanocytes and melanin in aminoglycoside-induced ototoxicity.

Main Methods:

  • Cell viability was assessed using the WST-1 assay to determine gentamicin's cytotoxic effect.
  • Activity of antioxidant enzymes, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), was measured in melanocytes exposed to gentamicin.

Main Results:

  • Gentamicin induced a concentration-dependent decrease in melanocyte viability, with an EC50 value of 7.5 mM.
  • Significant alterations in SOD, CAT, and GPx activity were observed in melanocytes treated with gentamicin.
  • These changes suggest a depletion of the antioxidant defense system within melanocytes.

Conclusions:

  • In vitro results indicate that gentamicin negatively impacts antioxidant enzymes in melanocytes.
  • Melanocytes and melanin may play a role in the mechanisms underlying gentamicin's ototoxicity.
  • Further research is warranted to elucidate the in vivo implications of these findings.